International consensus definition of disease flare in hidradenitis suppurativa
Br J Dermatol
.
2022 Nov;187(5):785-787.
doi: 10.1111/bjd.21647.
Epub 2022 Jul 25.
Authors
Tessa M LeWitt
1
,
Athena Mammis-Gierbolini
2
,
Michaela Parnell
3
,
Akua Sarfo
4
,
So Yeon Paek
5
,
Farida Benhadou
6
,
Véronique Del Marmol
6
,
Jennifer L Hsiao
7
,
Joslyn Kirby
8
,
Steven Daveluy
1
9
Affiliations
1
Wayne State University School of Medicine, Detroit, MI, USA.
2
Mt. Joy, PA, USA.
3
University of Salford, Salford, UK.
4
Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
5
Texas A&M College of Medicine, Dallas, TX, USA.
6
Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
7
Department of Dermatology, University of Southern California, Los Angeles, CA, USA.
8
Department of Dermatology, Penn State Health, Hershey, PA, USA.
9
Department of Dermatology, Wayne State University, Detroit, MI, USA.
PMID:
35531746
PMCID:
PMC9633352
DOI:
10.1111/bjd.21647
No abstract available
Publication types
Letter
MeSH terms
Consensus
Hidradenitis Suppurativa* / diagnosis
Humans
Severity of Illness Index
Symptom Flare Up
Grants and funding
R01 AR077122/AR/NIAMS NIH HHS/United States
UL1 TR002014/TR/NCATS NIH HHS/United States